Vasopressin receptor mutations in nephrogenic diabetes insipidus

被引:43
作者
Bichet, Daniel G. [1 ,2 ,3 ]
机构
[1] Hop Sacre Coeur, Res Ctr, Serv Nephrol, Montreal, PQ H4J 1C5, Canada
[2] Univ Montreal, Dept Physiol & Med, Res Ctr, Montreal, PQ, Canada
[3] Grp Etud Prot, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
nephrogenic diabetes insipidus; AVPR2; mutations; mutational analysis; misfolded mutants; pharmacological chaperones;
D O I
10.1016/j.semnephrol.2008.03.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this review is first to describe the importance of early detection of vasopressin receptor mutations responsible for X-linked nephrogenic diabetes insipidus (NDI). We have proposed that all families with hereditary diabetes insipidus should have their molecular defect identified because early diagnosis and treatment of affected infants can avert the physical and mental retardation that results from repeated episodes of dehydration. Secondly, 95 published missense mutations responsible for X-linked NDI are likely to result in misfolded arginine-vasopressin V2 receptors that are trapped in the endoplasmic reticulum. These misfolded receptors are unable to reach the plasma membrane in principal collecting duct cells and to engage the circulating antidiuretic hormone, arginine-vasopressin. These misfolded proteins potentially could be rescued with pharmacologic chaperones, an active area of research pertinent to other hereditary protein misfolding diseases such as cystic fibrosis, phenylketonuria, and Anderson-Fabry disease among many others. Finally, a long-term careful surveillance of all patients with hereditary NDI should be performed to prevent chronic renal failure likely caused by the long-term functional tract obstruction with reflux. © 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:245 / 251
页数:7
相关论文
共 30 条
[1]  
Arthus MF, 2000, J AM SOC NEPHROL, V11, P1044, DOI 10.1681/ASN.V1161044
[2]   Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans [J].
Bankir, L ;
Fernandes, S ;
Bardoux, P ;
Bouby, N ;
Bichet, DG .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :1920-1928
[3]   Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059 [J].
Bernier, V ;
Lagacé, M ;
Lonergan, M ;
Arthus, MF ;
Bichet, DG ;
Bouvier, M .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (08) :2074-2084
[4]   Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus [J].
Bernier, Virginie ;
Morello, Jean-Pierre ;
Zarruk, Alexandro ;
Debrand, Nicolas ;
Salahpour, Ali ;
Lonergan, Michle ;
Arthus, Marie-Francoise ;
Laperriere, Andre ;
Brouard, Remi ;
Bouvier, Michel ;
Bichet, Daniel G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (01) :232-243
[5]   Mutation of an A-kinase-anchoring protein causes long-QT syndrome [J].
Chen, Lei ;
Marquardt, Michelle L. ;
Tester, David J. ;
Sampson, Kevin J. ;
Ackerman, Michael J. ;
Kass, Robert S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20990-20995
[6]   High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor [J].
Cherezov, Vadim ;
Rosenbaum, Daniel M. ;
Hanson, Michael A. ;
Rasmussen, Soren G. F. ;
Thian, Foon Sun ;
Kobilka, Tong Sun ;
Choi, Hee-Jung ;
Kuhn, Peter ;
Weis, William I. ;
Kobilka, Brian K. ;
Stevens, Raymond C. .
SCIENCE, 2007, 318 (5854) :1258-1265
[7]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909
[8]   G protein-coupled receptor trafficking in health and disease: Lessons learned to prepare for therapeutic mutant rescue in vivo [J].
Conn, P. Michael ;
Ulloa-Aguirre, Alfredo ;
Ito, Joel ;
Janovick, Jo Ann .
PHARMACOLOGICAL REVIEWS, 2007, 59 (03) :225-250
[9]   The biological impact of mass-spectrometry-based proteomics [J].
Cravatt, Benjamin F. ;
Simon, Gabriel M. ;
Yates, John R., III .
NATURE, 2007, 450 (7172) :991-1000
[10]   The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints [J].
Fredriksson, R ;
Lagerström, MC ;
Lundin, LG ;
Schiöth, HB .
MOLECULAR PHARMACOLOGY, 2003, 63 (06) :1256-1272